On the public citation graph
Development of a Zn 2+-Chelating But Highly Selective Matrix Metalloproteinase 13 Inhibitor
0 signed · 16 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/art.10531openalex-extracted
Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro
inferredcites →https://doi.org/10.1002/cmdc.201700349openalex-extracted
Recent Research Advances in Selective Matrix Metalloproteinase‐13 Inhibitors as Anti‐Osteoarthritis Agents
inferredcites →https://doi.org/10.1016/j.bmc.2008.03.004openalex-extracted
High throughput screening of potentially selective MMP-13 exosite inhibitors utilizing a triple-helical FRET substrate
inferredcites →https://doi.org/10.1016/j.bmc.2014.07.025openalex-extracted
Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: Highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site
inferredcites →https://doi.org/10.1016/j.tox.2009.01.006openalex-extracted
Assessment of the renal toxicity of novel anti-inflammatory compounds using cynomolgus monkey and human kidney cells
inferredcites →https://doi.org/10.1021/acs.jmedchem.6b01007openalex-extracted
Discovery of Novel, Highly Potent, and Selective Matrix Metalloproteinase (MMP)-13 Inhibitors with a 1,2,4-Triazol-3-yl Moiety as a Zinc Binding Group Using a Structure-Based Design Approach
inferredcites →https://doi.org/10.1021/acs.jmedchem.7b00514openalex-extracted
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors
inferredcites →https://doi.org/10.1021/jm501284eopenalex-extracted
Characterization of Selective Exosite-Binding Inhibitors of Matrix Metalloproteinase 13 That Prevent Articular Cartilage Degradation in Vitro
inferredcites →https://doi.org/10.1021/jm9018788openalex-extracted
Oxetanes in Drug Discovery: Structural and Synthetic Insights
inferredcites →https://doi.org/10.1038/nri1418openalex-extracted
Matrix metalloproteinases as modulators of inflammation and innate immunity
inferredcites →https://doi.org/10.1038/sj.bjc.6600858openalex-extracted
Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis
inferredcites →https://doi.org/10.1039/c2md20111aopenalex-extracted
The developability of heteroaromatic and heteroaliphatic rings – do some have a better pedigree as potential drug molecules than others?
inferredcites →https://doi.org/10.1039/d0md00370kopenalex-extracted
Put a ring on it: application of small aliphatic rings in medicinal chemistry
inferredcites →https://doi.org/10.1074/jbc.m313474200openalex-extracted
Similarity of Binding Sites of Human Matrix Metalloproteinases
inferredcites →https://doi.org/10.1172/jci10564openalex-extracted
Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice
inferredcites →https://doi.org/10.2165/11318390-000000000-00000openalex-extracted
Matrix Metalloproteinase Inhibitors
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.